Bill
Bill > SB2549
TN SB2549
TN SB2549AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to buprenorphine products.
summary
Introduced
02/02/2026
02/02/2026
In Committee
Crossed Over
03/16/2026
03/16/2026
Passed
04/07/2026
04/07/2026
Dead
Signed/Enacted/Adopted
04/13/2026
04/13/2026
Introduced Session
114th General Assembly
Bill Summary
As enacted, adds that a healthcare provider who subcontracts through the contracted healthcare vendor with the department of correction may prescribe a buprenorphine product for the treatment of opioid use disorder if other certain listed criteria are met. - Amends TCA Title 53 and Title 63.
AI Summary
This bill amends Tennessee law to allow healthcare providers who are subcontracted through a vendor working with the Tennessee Department of Correction or a county or municipal jail to prescribe buprenorphine products for the treatment of opioid use disorder, provided other specific conditions are met. Buprenorphine is a medication used to treat opioid addiction, and this change aims to expand access to this treatment within correctional facilities.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
Effective date(s) 04/07/2026 (on 04/13/2026)
Bill Topics
Health
- ‐ Drug Abuse, Treatment, and Education
Law, Crime, and Family Issues
- ‐ Prisons and Correctional Institutions
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location | Created |
|---|---|---|
| State Bill Page | https://wapp.capitol.tn.gov/apps/Billinfo/Default?BillNumber=SB2549&ga=114 | 02/03/2026 |
| BillText | https://publications.tnsosfiles.com/acts/114/pub/pc0677.pdf | 04/13/2026 |
| Fiscal Note - HB1954 | https://www.capitol.tn.gov/Bills/114/Fiscal/HB1954.pdf | 02/13/2026 |
| BillText | https://www.capitol.tn.gov/Bills/114/Bill/SB2549.pdf | 02/03/2026 |
Loading...